You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
146. Baehner FL Quantitative RT-PCR analysis of <strong>ER</strong> and PR by oncotype DX<br />
indicates distinct and different associations with prognosis and prediction of<br />
tamoxifen benefits. 29th San Antonio Breast Cancer Symposium (abstract 45).<br />
Breast cancer Res Treat 2006; 100: S20, San Antonio, TX, 2006<br />
147. Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge<br />
RM 2005 Estrogen receptor-positive, progesterone receptor-negative breast<br />
cancer: association with growth factor receptor expression and tamoxifen<br />
resistance. J Natl Cancer Inst 97:1254-61<br />
148. Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson<br />
C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp<br />
H, Slamon DJ 2003 Quantitative association between H<strong>ER</strong>-2/neu and steroid<br />
hormone receptors in hormone receptor-positive primary breast cancer. J Natl<br />
Cancer Inst 95:142-53.<br />
149. Dowsett M, Bundred NJ, Decensi A, Sainsbury RC, Lu Y, Hills MJ, Cohen<br />
FJ, Veronesi P, O'Brien ME, Scott T, Muchmore DB 2001 Effect of raloxifene<br />
on breast cancer cell Ki67 and apoptosis: a double- blind, placebo-controlled,<br />
randomized clinical trial in postmenopausal patients. Cancer Epidemiol<br />
Biomarkers Prev 10:961-6.<br />
150. Balleine RL, Earl MJ, Greenberg ML, Clarke CL 1999 Absence of<br />
progesterone receptor associated with secondary breast cancer in postmenopausal<br />
women. Br J Cancer 79:1564-71.<br />
151. Bamberger AM, Milde-Langosch K, Schulte HM, Loning T 2000<br />
Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations<br />
63
Change language